VRTX · Vertex Pharmaceuticals Inc / Ma · Analyst Estimates
$522.81
-3.92 (-0.74%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$133.37B
Shares
253.46M
Volume · Sep 30
1.15M
Avg daily vol (3M)
1.23M
Analyst Estimates
Compare analyst forecasts for Vertex Pharmaceuticals Inc / Ma across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-29 11:52 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.72
|
16.17139
|
19.31
|
— |
19.03728
|
19.04863
|
16.16939
|
19.14589
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
15
|
— | — | — | — |
7
|
1
|
5
|
1
|
|
Revenue
USD
Publication date not stated |
13159454320
|
13247981150
|
13385000000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
16
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
17.7
|
20.10614
|
22.89
|
— |
21.99736
|
21.50969
|
20.0928
|
21.47137
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
15
|
— | — | — | — |
5
|
0
|
8
|
2
|
|
Revenue
USD
Publication date not stated |
13886000000
|
14550907290
|
15234200000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
15
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-29.56
|
-1.21986
|
5.06
|
— |
4.91964
|
4.90738
|
-1.73713
|
4.95004
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
12
|
— | — | — | — |
7
|
0
|
5
|
1
|
|
Revenue
USD
Publication date not stated |
3320400000
|
3414347540
|
3502553000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
13
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
4.04048
|
4.56311
|
5.05
|
— |
4.93739
|
5.00637
|
4.56254
|
5.0284
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
13
|
— | — | — | — |
8
|
0
|
3
|
1
|
|
Revenue
USD
Publication date not stated |
3454400000
|
3526023420
|
3609000000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
14
|
— | — | — | — | — | — | — | — |
Key facts
CIK
875320
CUSIP
92532F100
13F (30d)
41 filings
23 filers
Visit website
Investor relations